Home › Funds › Citigroup Inc › ADAPY
Citigroup Inc position in ADAPY
ADAPTIMMUNE THERAPEUTICS PLC · Materials
Latest position (Q3 2025)2.68K sh
Reported value held$348
Portfolio Weight0.00%
First reportedQ3 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 41.99K | $217.00K | New |
| Q4 2021 | 30.05K | $113.00K | Reduce |
| Q1 2022 | 21.54K | $44.00K | Reduce |
| Q2 2022 | 31.43K | $53.00K | Add |
| Q3 2022 | 6.65K | $7.00K | Reduce |
| Q4 2022 | 1.96K | $2.87K | Reduce |
| Q1 2023 | 1.66K | $1.80K | Reduce |
| Q2 2023 | 582.20K | $538.53K | Add |
| Q3 2023 | 582.27K | $454.18K | Hold |
| Q3 2025 | 2.68K | $348 | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ADAPY
No other tracked fund reports a position in ADAPY.